Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Addendum, aka, anemia, appended, argument, book, Bridge, cisplatin, clarify, Code, Confidence, DCR, deactivated, deferral, double, emerged, ESMO, flat, focused, gemcitabine, Hazard, IDTA, Interval, intervene, judgement, Molecular, multitude, neutropenia, outsource, passage, perioperative, prolonged, ratio, reactivated, reregister, resolution, session, Supplier, temporary, tripeptide, unconditionally, worsening
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view